Correlation Between Viking Therapeutics and Verrica Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Viking Therapeutics and Verrica Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viking Therapeutics and Verrica Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Viking Therapeutics and Verrica Pharmaceuticals, you can compare the effects of market volatilities on Viking Therapeutics and Verrica Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viking Therapeutics with a short position of Verrica Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viking Therapeutics and Verrica Pharmaceuticals.
Diversification Opportunities for Viking Therapeutics and Verrica Pharmaceuticals
0.69 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Viking and Verrica is 0.69. Overlapping area represents the amount of risk that can be diversified away by holding Viking Therapeutics and Verrica Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Verrica Pharmaceuticals and Viking Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viking Therapeutics are associated (or correlated) with Verrica Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Verrica Pharmaceuticals has no effect on the direction of Viking Therapeutics i.e., Viking Therapeutics and Verrica Pharmaceuticals go up and down completely randomly.
Pair Corralation between Viking Therapeutics and Verrica Pharmaceuticals
Given the investment horizon of 90 days Viking Therapeutics is expected to generate 0.77 times more return on investment than Verrica Pharmaceuticals. However, Viking Therapeutics is 1.29 times less risky than Verrica Pharmaceuticals. It trades about -0.18 of its potential returns per unit of risk. Verrica Pharmaceuticals is currently generating about -0.25 per unit of risk. If you would invest 5,199 in Viking Therapeutics on September 25, 2024 and sell it today you would lose (974.00) from holding Viking Therapeutics or give up 18.73% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Viking Therapeutics vs. Verrica Pharmaceuticals
Performance |
Timeline |
Viking Therapeutics |
Verrica Pharmaceuticals |
Viking Therapeutics and Verrica Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Viking Therapeutics and Verrica Pharmaceuticals
The main advantage of trading using opposite Viking Therapeutics and Verrica Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viking Therapeutics position performs unexpectedly, Verrica Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Verrica Pharmaceuticals will offset losses from the drop in Verrica Pharmaceuticals' long position.Viking Therapeutics vs. Fate Therapeutics | Viking Therapeutics vs. Caribou Biosciences | Viking Therapeutics vs. Arcus Biosciences | Viking Therapeutics vs. Karyopharm Therapeutics |
Verrica Pharmaceuticals vs. Oric Pharmaceuticals | Verrica Pharmaceuticals vs. Lyra Therapeutics | Verrica Pharmaceuticals vs. Inhibrx | Verrica Pharmaceuticals vs. ESSA Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Other Complementary Tools
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |